This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Interventional, randomised, double-blind, parallel...
Clinical trial

Interventional, randomised, double-blind, parallel-group, placebo-controlled, flexible-dose study of brexpiprazole as adjunctive treatment to paroxetine or sertraline in adult patients suffering from post-traumatic stress disorder (PTSD)

Read time: 1 mins
Last updated:11th Oct 2013
To evaluate the efficacy of brexpiprazole up to 3 mg/day as adjunctive treatment to paroxetine or sertraline on PTSD symptoms
Category Value
Study start date 2013-10-11

View full details